INTERNATIONAL PATENT: ALTEOGEN INC., (주)알테오젠 FILES APPLICATION FOR "USE OF SUBCUTANEOUS INJECTION FORMULATION COMPRISING HYALURONIDASE USED IN COMBINATION WITH ANTIBODY-DRUG CONJUGATE AND METHOD FOR TREATING DISEASE BY USING SAME"

GENEVA, April 7 -- ALTEOGEN INC. (62, Yuseong-daero 1628beon-gilYuseong-guDaejeon 34054), (주)알테오젠 (대전광역시유성구유성대로1628번길 62) filed a patent application (PCT/KR2025/015130) for "USE OF SUBCUTANEOUS INJECTION FORMULATION COMPRISING HYALURONIDASE USED IN COMBINATION WITH ANTIBODY-DRUG CONJUGATE, AND METHOD FOR TREATING DISEASE BY USING SAME" on Sep 25, 2025. With publication no. WO/2026/071755, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectua...